Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Home
Find People
Find Everything
About This Site
Annual Report
Export RDF

Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Wagner J, Leeder JS. Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children. Pediatr Clin North Am. 2012 Oct; 59(5):1017-37.

View in: PubMed

subject areas

Adult
Child
Cholesterol, LDL
Dose-Response Relationship, Drug
Dyslipidemias
Genetic Variation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pediatrics
Pharmacogenetics
Research Design

authors with profiles

J. Steven Leeder
Jonathan B. Wagner